The Effects of Subconcussive Events on Cognition

April 7, 2022 updated by: Matthew Heller, New York Institute of Technology
The purpose of this study is to determine early detection of concussion for those at risk of developing symptoms and to be able to detect subconcussive cerebral impairment, and thus gaining a better understanding of the injury patterns for concussions in Men's and Women's Collegiate sports.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Description of the Research Subjects will be members of NYIT's Collegiate Athletic Teams. Potential subjects will be informed about the proposed study and asked if the athlete is interested in participating. If the athlete agrees, the key investigator will review the study procedures, what is expected of the subject, and complete the informed consent process. Participation will be completely voluntary and will have no impact on the quality of care the subject will receive. Inclusion and exclusion criteria will then be evaluated by the key investigator to determine if the subject is qualified to participate in this study. Following consent and review of inclusion and exclusion criteria, the subject will be assigned a subject identification number in which is intended to maintain confidentiality of the subject's personal health information. The number will be used for the duration of the study and in all analyses. Once enrolled, the subjects will complete a baseline questionnaire* that will include demographic information and personal history, as well as consent for de-identified information to be shared with a third party, Quadrant Biosciences, for research purposes. The subjects will be evaluated by a series of measurements, ClearEdge, Quadrant Bioscience Salivary Testing, King Devick, and Im PACT, in the preseason, midseason, and postseason, or if they are suspected of a concussion by the athletic trainer or team physician. Visit 1: Baseline Data Collection

  • Assessment Tools
  • Demographic/Baseline questionnaire*
  • ImPACT
  • King-Devick
  • ClearEdge New York Institute of Technology Institutional Review Board Approved From 07/18/20 to 07/17/21
  • Quadrant Bioscience Salivary Testing
  • Quadrant Bioscience Salivary Testing Questionnaire
  • Estimated Time: 1.5 hours Visit 2: Mid-Season Collection
  • Assessment Tools
  • ImPACT
  • King-Devick
  • ClearEdge
  • Quadrant Bioscience Salivary Testing
  • Quadrant Bioscience Salivary Testing Questionnaire
  • Estimated time: 1 hour Visit 3: Post-season Data Collection
  • Assessment Tools
  • ImPACT
  • King-Devick
  • ClearEdge
  • Quadrant Bioscience Salivary Testing
  • Quadrant Bioscience Salivary Testing Questionnaire
  • Estimated time: 1 hr Visit 4: If athlete is suspected to have sustained a concussion by the athletic trainer or team physician, the athlete will come for an additional visit
  • Assessment Tools
  • ImPACT
  • King-Devick
  • ClearEdge
  • Quadrant Bioscience Salivary Testing
  • Quadrant Bioscience Salivary Testing Questionnaire
  • Estimated time: 1 hr

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Old Westbury, New York, United States, 11568
        • New York Institute of Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Subjects for this study will be members of the NYIT Athletic Teams.

Description

Inclusion Criteria:

  • Subject is at least 18 years age and younger than 50 years of age
  • Subject experiences at least 8Gs of force on at least one occasion, as measured by accelerometer

Exclusion Criteria:

  • The subject suffered from any of the following at the time of event leading to a concussion:

    • Loss of consciousness >2 minutes in the field as reported by witness
    • Seizures
    • Intractable vomiting
    • Paralysis
  • The subject has been diagnosed with an underlying neurodegenerative condition that may confound test results (e.g. Parkinson's Disease, Alzheimer's Disease)
  • The subject has a current or previous spinal cord injury
  • The subject is unable to complete assessment tools
  • The subject is pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cognition secondary to impact
Time Frame: 5 months
A mouthguard with built in sensors to collect data above the predetermined acceleration thresholds. The predetermined threshold for acceleration will be set to 5G in order to collect more data about subconcussive impacts, in addition to concussive impacts
5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ImPACT Testing
Time Frame: 5 months
Tool to help detect and assess the severity of concussion in athletes by establishing a baseline of memory and cognitive function
5 months
King-Devick Test
Time Frame: 5 months
Objectively measures visual tracking and saccadic eye movements
5 months
C3 Logix
Time Frame: 5 months
Concussion Assessment application with the ability to track a patient's dynamic vision reflexes and ability to focus on moving objects
5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew Heller, D.O, New York Institute of Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2018

Primary Completion (Actual)

July 3, 2018

Study Completion (Actual)

March 13, 2020

Study Registration Dates

First Submitted

December 20, 2017

First Submitted That Met QC Criteria

January 6, 2018

First Posted (Actual)

January 9, 2018

Study Record Updates

Last Update Posted (Actual)

April 14, 2022

Last Update Submitted That Met QC Criteria

April 7, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

May share with osteopathic medical research students

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Injury

Clinical Trials on Vector Mouthguard

Subscribe